Quality Metrics for better Quality Compliance

Slides:



Advertisements
Similar presentations
Basic Principles of GMP
Advertisements

Building a Cradle-to-Grave Approach with Your Design Documentation and Data Denise D. Dion, EduQuest, Inc. and Gina To, Breathe Technologies, Inc.
Session No. 4 Implementing the State’s Safety Programme Implementing Service Providers SMS
Overview Lesson 10,11 - Software Quality Assurance
Quality System Model ICH Q10
FIELD COMPLIANCE UPDATE CDR Thomas R. Berry, RPh FDA, Investigator RAL-RP / ATL-DO.
Session No. 4 Implementing Service Providers SMS Implementing the State’s Safety Programme SMS Senior Management Workshop Rome, 21 May 2007.
Session No. 3 ICAO Safety Management Standards ICAO SMS Framework
EHS Management System Elements
Regulatory Update Ellen Leinfuss SVP, Life Sciences.
Global Quality Operations Sustaining Quality ^ : Why is Quality Good for Business? Diane E. Bergeron Vice President Global Quality Operations Schering-Plough.
Organize to improve Data Quality Data Quality?. © 2012 GS1 To fully exploit and utilize the data available, a strategic approach to data governance at.
Good Manufacturing Practice. Good Manufacturing Practice Regulations Establishes minimum GMP for methods to be used, and the facilities or controls to.
FDA Regulation of Drug Quality: New Challenges Janet Woodcock, M.D. Director, Center for Drug Evaluation and Research, Food and Drug Administration April.
FDA’s Perspective on the “Pharmaceutical cGMPs for the 21st Century” Initiative David J. Horowitz, Esq. Director, CDER/FDA, Office of Compliance Advisory.
Important informations
How to audit the role of the vendor in the conduct of outsourced studies Kristel Van de Voorde Director Global Quality Regulatory Compliance Bristol-Myers.
Case for Quality Initiative Industry Perspective Monica J. Wilkins April 30, 2013.
Quality by Design & Question-Based Review: Observations by the Generic Pharmaceutical Industry Advisory Committee for Pharmaceutical Science October 5,
PhRMA Perspective on FDA Final Report FDA Advisory Committee on Pharmaceutical Sciences October 20, 2004 G.P. Migliaccio, Pfizer Inc.
Molecule-to-Market-Place Quality
104TPDA04036-C IMPLEMENTING QUALITY METRICS IN BIOPHARMACEUTICAL COMPANIES For Taiwan PDA Ben Chen, P.E. November 16, 2015.
ISO CONCEPTS Is a management standard, it is not performance or product standard. The underlying purpose of ISO 1400 is that companies will improve.
CDER / Office of Compliance ACPS October 5, 2006 Joseph C. Famulare Acting Deputy Director Office of Compliance CDER / FDA.
MDIC/Xavier University Device Product Quality Metrics December 8, 2015.
Continual Service Improvement Methods & Techniques.
Good Manufacturing Practice (GMP) Compliance: GMPs EXPLAINED.
© Pharmaceutical Consultancy Services, All rights reserved. Quality System(s) Jaap Koster.
Department of Defense Voluntary Protection Programs Center of Excellence Development, Validation, Implementation and Enhancement for a Voluntary Protection.
© 2011 Pharmaceutical Consultancy Services, All Rights Reserved. Management Review Concordiaplein VV Haastrecht, the Netherlands Tel
Phase-1: Prepare for the Change Why stepping back and preparing for the change is so important to successful adoption: Uniform and effective change adoption.
KEVIN BEDAL LISA CARLIN MATT CARROLL ERIN NICHOLS Product Safety & Failure Analysis.
eQMS Implementation at CoorsTek Medical
ANNUAL PRODUCT REVIEW Patchara Kootiratrakarn Independent consultant.
Building evaluation in the Department of Immigration and Citizenship
Software Quality Control and Quality Assurance: Introduction
ISO 14001: 2004 Environmental Management Review Presentation
How can an Enterprise Risk Management (ERM), programme enable organizations achieve strategic objectives more effectively? Dr P S Sahota  
Irena Prat and Josée Hansen World Health Organization
WP 3 How to assess implementation of ALARA
Quality Risk Management
Pharmaceutical Quality in the 21st Century
The Systems Engineering Context
American Society for Quality Region 5 Quality Conference
Safety Accountabilities
Quality Risk Management
Overview – Guide to Developing Safety Improvement Plan
MGT 498 Education for Service-- snaptutorial.com.
MGT 498 TUTORIAL Lessons in Excellence -- mgt498tutorial.com.
MGT 498 Teaching Effectively-- snaptutorial.com
MDIC- Case for Quality Forum
Making Information Security Manageable with GRC
Overview – Guide to Developing Safety Improvement Plan
Higher physical education
Making Information Security Actionable with GRC
An Integrated Food Safety System When Will You Know it is Here ?
Articulate how the practice of management has evolved
The “Why” and “What” of Safety Management Systems
PAI Readiness For Seven ANDA Products
New Facility Preparation for Pre-Approval Inspection PHARMACEUTICAL INDUSTRY Client A large pharmaceutical company contracted.
The International Drug Safety Paradigm
Capability Maturity Model
An Update of COSO’s Internal Control–Integrated Framework
Risky Business Standalone ISO9001:2015 Risk-Based Thinking and Integration of Risk Management with ISO9001:2015.
Dr Manisha Shridhar Regional Advisor WHO-SEARO
Capability Maturity Model
An overview of Internal Controls Structure & Mechanism
SAFETY PERFORMANCE TARGETS
Optimizing Your Help Desk:
Manufacture of Sterile Medicinal Products: ‘Annex 1’ - DRAFT
Presentation transcript:

Quality Metrics for better Quality Compliance Dr. Raghunandan H.V.| JSS University

Agenda How does industry use Metrics? FDA Challenges and Requirements and Use Complexities of Implementation (Industry Feedback) What does it all mean???

Industry use of Metrics

Regulatory Intelligence QMS Regulatory Guidance Regulatory Intelligence Validation Data Product Data Learning’s Data Training Data Vendor Data Specifications Data Laboratory Data Support  Development,  Manufacturing,  Compliance and  Flexibility Application  Integrate QRM into process  Make Use of data and use QRM to convert data to information Know what comes next Predict what will happen Document rationale Create Understanding ICH Q8 Knowledge Management Raw Facts Filter Risks Learning Data Information Knowledge Understanding Put facts in a context Guidance for action What to use for what purpose

Metrics and Trending Key in Risk identification – systematic use of information to identify potential sources of harm (hazards) referring to the risk question or problem description [ICH Q9 / Definitions] Enables the detection of potential problems as early as possible to plan corrective and preventive actions Provides indication that controls are losing effectiveness Important in achieving problem resolution and problem prevention Another important concept of modern quality systems is the use of trending to examine processes as a whole.

Cost of Quality Analysis RISK AND ESCALATION RISK VISIBILITY Quantity Management Review Cost of Quality Analysis Recall Committee Material Review Board Process Improvement Efficiencies Stability Trending Annual Product Review Product Complaints Deviations OOS Self Inspection

FDA Challenges and Requirements

FDA Challenges What about Quality? What about flexibility? FARs have increased Recalls have increased Shortages have increased Lack of common measuring stick What about flexibility? Supplement trends continue unabated What about workload Significant increases in application numbers Increasingly complex Increasingly global What about focus? More on review (predicting) than on post market surveillance Compliance or quality?

Potential Task of Industry Each FEI site reports the following (per CY) – stratify by product and/or application number  # of lots attempted  # of lots rejected  # of lots reworked or re-porcessed  # of lot release tests conducted  # of OOS results  # of lot release results invalidated

How will FDA Use Metrics? Assist to segment sites for risk based inspection schedule Risk based inspection schedule required under FDASIA, Title VII, section 705 Assist to segment products (and/or processes) and individual product manufacturers based on risk Potentially predictive of future drug shortages Basis of structured (objective) component of inspection and review Only one element of risk assessment Not to issue “restaurant style grades” Where do you stand relative to industry groupings

CDER CBER Biologicals Drugs Quality Metrics – FDA Guidance (CDER & CBER) Quality metrics are used throughout the drugs and biologics industry to monitor quality control systems and processes and drive continuous improvement efforts in drug manufacturing May require more than one slide

Complexities of Implementation (Industry Feedback)

Complexities Many existing metrics are lagging indicators as opposed to leading indicators Clarity of Definitions among highly diverse contingent (API, small molecule, large molecule, etc.. Concerns around cultural impacts of reporting metrics CMO Management (Product vs. Site) Virtual companies and expectations Global Implications (reporting requirements from other countries/language implications)

Quality Culture Quality Culture plays a key role: Open and honest communication Clear vision and belief in quality Management leadership/sponsorship Listening Training and implementation of Continuous Improvement

Industry Recommended Metrics

Other Metrics being considered Process Capability CpK, PpK, etc. Critical Investigations Rate CAPA Effectiveness Rate Quality System Effectiveness Environmental Monitoring Rate AE Rates Deviations Rates Recall Rate Repeat CAPA rate Right first Time rate Unplanned Downtime Indicators of ongoing investment/maintenance

Benefits and Risks